Evidence map›Paper›PMID 31584957›Full record

ArticlePloS one2019

Substitution of marijuana for opioids in a national survey of US adults.

Julie H Ishida, Peggy O Wong, Beth E Cohen, Marzieh Vali, Stacey Steigerwald, Salomeh Keyhani

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Analyzing the Impact of Cannabinoids on the Treatment of Spinal Disorders.Current reviews in musculoskeletal medicine · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  15. Review
  16. Article
  17. Article
  18. Cannabis: An Emerging Treatment for Common Symptoms in Older Adults.Journal of the American Geriatrics Society · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Julie H IshidaDepartment of Medicine, Division of Nephrology, San Francisco VA Medical Center, San Francisco, California, United States of America.
Peggy O WongDepartment of General Internal Medicine, San Francisco VA Medical Center, San Francisco, California, United States of America.ORCID 0000-0002-0510-9203
Beth E CohenDepartment of General Internal Medicine, San Francisco VA Medical Center, San Francisco, California, United States of America.
Marzieh ValiDepartment of General Internal Medicine, San Francisco VA Medical Center, San Francisco, California, United States of America.
Stacey SteigerwaldDepartment of General Internal Medicine, San Francisco VA Medical Center, San Francisco, California, United States of America.
Salomeh KeyhaniDepartment of General Internal Medicine, San Francisco VA Medical Center, San Francisco, California, United States of America.ORCID 0000-0001-9124-9618
San Francisco VA Medical Center · US

Funding

Impact of marijuana on adherence, risk factor control and cardiovascular eventsR01HL130484 · NHLBI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI KEYHANI, SALOMEH · 2017 to 2020
$2.9M
Facilitating Appropriate Analgesic Prescription in Hemodialysis PatientsK23DK103963 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ISHIDA, JULIE · 2015 to 2018
$621k
NHLBI NIH HHS R01 HL130484NIDDK NIH HHS K23 DK103963
6 · The paper itself

Abstract

Opioid prescriptions for chronic pain and subsequent opioid-related complications have risen dramatically in the US. Recent data suggest that medical marijuana laws have been associated with lower state-level opioid overdose mortality. In a national survey, we examined the prevalence of substitution of marijuana for opioids among US adults taking opioids for pain.Using GfK's KnowledgePanel, we conducted an Internet-based survey of a nationally representative sample of 16,280 adults in 2017 about individual perceptions and use of marijuana. We developed questions designed to assess the extent and reasons for substitution of marijuana for opioids. We examined opioid substitution among respondents with a history of ever using marijuana who used opioids in the past 12 months. There were 9,003 respondents, corresponding to a 55.3% response rate. The mean age was 48 years. Among the 5% (n = 486) who reported ever using marijuana and using opioids in the past year, 43% used opioids daily, and 23% reported current (past 30 day) marijuana use. Forty-one percent reported a decrease or cessation of opioid use due to marijuana use; 46% reported no change in opioid use; and 8% reported an increase in opioid use. We found that a substantial number of US adults reported that they substituted marijuana for opioids.

Indexed as

AdolescentAdultAnalgesics, OpioidChronic PainDrug PrescriptionsFemaleHumansMaleMedical MarijuanaMiddle AgedOpioid-Related DisordersPain ManagementSurveys and QuestionnairesUnited StatesYoung AdultAnalgesics, OpioidMedical Marijuana

Identifiers

PMID31584957
PMCPMC6777788
OpenAlexW2977253050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.